PASD1 and diffuse large B-cell lymphoma: One of the antigens, OX-TES-1, was recognised by serum from four out of 10 patients with DLBCL, one out of 20 normal serum samples and no acute myeloid leukaemia (AML) or chronic myeloid leukaemia (CML) serum samples (n=10 of each).